Acorda Therapeutics
Latest round
- Series C
Last raised
- May 2003
Total raised
- $89M
Investors
- 12
About Acorda Therapeutics
Acorda Therapeutics, Inc.Acorda Therapeutics, Inc. specializes in therapies for neurological disorders., the company has undergone various strategic developments over the years. The current CEO is Ron Cohen.Acorda Therapeutics Inc. specializes in developing and commercializing innovative therapies for neurological diseases. Their core offerings include AMPYRA® (dalfampridine), a treatment designed to improve walking in patients with multiple sclerosis, and INBRIJA® (levodopa inhalation powder), utilized for managing off periods in patients with Parkinson's disease. These products aim to alleviate symptoms and enhance the quality of life for individuals facing challenges from these neurological conditions.63 mn in 2023. The company's revenue is driven by the sale of its pharmaceutical products, particularly AMPYRA® and INBRIJA®. Transactions typically involve wholesalers purchasing the products at wholesale prices, which are subsequently sold to healthcare providers and pharmacies, ensuring access for end users. The company is focusing on upcoming therapies and is targeting regions that include Europe and specific markets in North America.
Who invested in Acorda Therapeutics
12 investors across 2 rounds
See all investors in Acorda Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Acorda Therapeutics
Who invested in Acorda Therapeutics?
Acorda Therapeutics has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Acorda Therapeutics raised?
Acorda Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Acorda Therapeutics last raise money?
Acorda Therapeutics's most recent round on record is a Series C, in May 2003.
What does Acorda Therapeutics do?
Acorda Therapeutics is a pharmaceuticals company.
Where is Acorda Therapeutics headquartered?
Acorda Therapeutics is headquartered in US.
Which VCs invest in companies like Acorda Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Acorda Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Acorda Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.